Choose the correct statement about nateglinide

A) It is a long acting oral hypoglycaemic drug B) Taken just before a meal, it limits postprandial hyperglycaemia in type 2 diabetes mellitus C) It lowers blood glucose in both type 1 and type 2 diabetes mellitus D) It acts by opening K⁺ channels in myocytes and adipocytes